Ing. Tomáš Goláň
ODS
Twitter
NEKONTROLOVÁNO
Obsah příspěvku
Due to secondary infections during COVID-19, antimicrobial resistance (AMR) is on the rise, and some infections are increasingly untreatable. The biopharmaceutical industry continues R&D against this threat but reforms are needed to address this challenge head on.
Screenshot
Screenshot není k dispozici
Metadata
| Platforma | Twitter (social) |
| Publikováno | 21.07.2022 17:17 |
| První viděn | 12.04.2026 02:01 |
| Poslední kontrola | dosud nekontrolováno |
| Počet slov | 0 |
| Hlídač ID | 7e7769a77184763db6a71b43530be0cf |
| Original ID | 1550168126842671104 |
| Zdrojová URL | https://twitter.com/golan_tomas/status/1550168126842671104 |